Kussmaul breathing

From WikiMD's WELLNESSPEDIA


Overview[edit]

Diagram of breathing abnormalities, including Kussmaul breathing

Kussmaul breathing is a type of deep and labored breathing pattern often associated with severe metabolic acidosis, particularly diabetic ketoacidosis (DKA) but also kidney failure. It is a form of hyperventilation, which is any breathing pattern that reduces carbon dioxide in the blood due to increased rate or depth of respiration.

History[edit]

Kussmaul breathing is named after the German doctor Adolf Kussmaul, who first described the phenomenon in 1874. He observed this type of breathing in patients with diabetes mellitus who were in a state of ketoacidosis.

Pathophysiology[edit]

Kussmaul breathing is a compensatory mechanism for metabolic acidosis. In conditions such as diabetic ketoacidosis, the body produces excess ketone bodies, leading to a decrease in blood pH. The respiratory system compensates by increasing the rate and depth of breathing to expel more carbon dioxide, which is acidic, thereby helping to raise the blood pH back towards normal.

Clinical Presentation[edit]

Patients exhibiting Kussmaul breathing will have a noticeable increase in the depth and rate of their breathing. This is often described as "air hunger". Unlike other forms of dyspnea, Kussmaul breathing is not associated with a feeling of breathlessness, but rather a physiological response to acidosis.

Differential Diagnosis[edit]

Kussmaul breathing should be differentiated from other types of abnormal breathing patterns such as:

Management[edit]

The primary treatment for Kussmaul breathing is to address the underlying cause of the metabolic acidosis. In the case of diabetic ketoacidosis, this involves the administration of insulin and fluids. In cases of renal failure, dialysis may be necessary.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.